Cargando…
Combined epigenetic/genetic study identified an ALS age of onset modifier
Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27–74 years in carriers of the G(4)C(2)-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genet...
Autores principales: | Zhang, Ming, Xi, Zhengrui, Saez-Atienzar, Sara, Chia, Ruth, Moreno, Danielle, Sato, Christine, Montazer Haghighi, Mahdi, Traynor, Bryan J., Zinman, Lorne, Rogaeva, Ekaterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066440/ https://www.ncbi.nlm.nih.gov/pubmed/33892821 http://dx.doi.org/10.1186/s40478-021-01183-w |
Ejemplares similares
-
DNA methylation age acceleration is associated with ALS age of onset and survival
por: Zhang, Ming, et al.
Publicado: (2020) -
The Intersection between COVID-19, the Gene Family of ACE2 and
Alzheimer’s Disease
por: Haghighi, Mahdi Montazer, et al.
Publicado: (2020) -
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis
por: Chia, Ruth, et al.
Publicado: (2022) -
DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients
por: Zhang, Ming, et al.
Publicado: (2017) -
Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)